Pericardial Patches Market Size & Share, by Type (Synthetic Pericardial Patches, Biological Pericardial Patches); Source (Bovine, Porcine, Equine); Application (Cardiovascular Surgery, Heart Valve Repair, Congenital Heart Defects, Dental Surgery); End user (Hospitals, Specialty Clinics, Ambulatory Surgical Center, Research and Academic Institutes) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2025-2037

Request Free Sample Copy

Report ID: 4589
Published Date: Nov 29, 2024
Report Format: PDF, PPT

Buy Now

Global Pericardial Patches Market

Introduction
1. Study Objective
2. Scope of the report
3. Market Taxonomy
Study Assumptions and Abbreviations
1. Research Methodology
2. Secondary Research
3. Primary Research
4. SPSS Approach
5. Data Triangulation
Executive Summary
Global Industry Overview Market Overview
1. Market Overview
2. Regional Synopsis
3. Industry Supply Chain Analysis
4. DROTs
5. Government Regulation: How they would Aid the Business?
6. Competitive Landscape
  1. ARTIVION, INC
  2. Abbott Laboratories
  3. Baxter International.
  4. Collagen Solutions (US) LLC
  5. Edwards Lifesciences Corporation
  6. FOC Medical S.A.
  7. Labcor Laboratórios Ltda
  8. LeMaitre Vascular, Inc.
  9. Visionary Medtech Solutions Pvt. Ltd.
  10. W. L. Gore & Associates, Inc.
7. Ongoing Technological Advancements
8. Price Benchmarking
9. SWOT Analysis
10. Unique Selling Proposition (USP)
11. Startup Overview
12. End user in Pericardial Patches
13. Root Cause Analysis
14. Business Expansion in Different Region
15. Porter’s Five Forces
16. Pericardial Patches Utilization in Medical Devices Developed by iVascular
17. Key Players in the Market
18. Recent Development Analysis
19. Industry Risk Assessment
Gobal Outlook and Projections
1. Global Overview
  1. Market Value (USD Million), Current and Future Projections, 2024-2037
  2. Increment $ Opportunity Assessment, 2024-2037
  3. Year-on-Year Growth Forecast (%)
2. Global Segmentation (USD Million), 2024-2037, By
  1. Type, Value (USD Million)
    1. Synthetic Pericardial Patches
    2. Biological Pericardial Patches
      1. Autologous
      2. Xenograft
  2. Source, Value (USD Million)
    1. Bovine
    2. Porcine
    3. Equine
    4. Others
  3. Application, Value (USD Million)
    1. Cardiovascular Surgery
    2. Heart Valve Repair
    3. Congenital Heart Defects
    4. Dental Surgery
    5. Others
  4. End user, Value (USD Million)
    1. Hospitals
    2. Specialty Clinics
    3. Ambulatory Surgical Center
    4. Research and Academic Institutes
  5. Regional Synopsis (USD Million), 2024-2037
    1. North America, Value (USD Million)
    2. Europe, Value (USD Million)
    3. Asia Pacific, Value (USD Million)
    4. Latin America, Value (USD Million)
    5. Middle East and Africa, Value (USD Million)
North America Market
1. Overview
  1. Market Value (USD Million), Current and Future Projections, 2024-2037
  2. Increment $ Opportunity Assessment, 2024-2037
  3. Year-on-Year Growth Forecast (%)
2. Segmentation (USD Million), 2024-2037, By
  1. Type, Value (USD Million)
    1. Synthetic Pericardial Patches
    2. Biological Pericardial Patches
      1. Autologous
      2. Xenograft
  2. Source, Value (USD Million)
    1. Bovine
    2. Porcine
    3. Equine
    4. Others
  3. Application, Value (USD Million)
    1. Cardiovascular Surgery
    2. Heart Valve Repair
    3. Congenital Heart Defects
    4. Dental Surgery
    5. Others
  4. End user, Value (USD Million)
    1. Hospitals
    2. Specialty Clinics
    3. Ambulatory Surgical Center
    4. Research and Academic Institutes
  5. Country Level Analysis, Value (USD Million)
    1. U.S.
    2. Canada
Europe Market
1. Overview
  1. Market Value (USD Million), Current and Future Projections, 2024-2037
  2. Increment $ Opportunity Assessment, 2024-2037
  3. Year-on-Year Growth Forecast (%)
2. Segmentation (USD Million), 2024-2037, By
  1. Type, Value (USD Million)
    1. Synthetic Pericardial Patches
    2. Biological Pericardial Patches
      1. Autologous
      2. Xenograft
  2. Source, Value (USD Million)
    1. Bovine
    2. Porcine
    3. Equine
    4. Others
  3. Application, Value (USD Million)
    1. Cardiovascular Surgery
    2. Heart Valve Repair
    3. Congenital Heart Defects
    4. Dental Surgery
    5. Others
  4. End user, Value (USD Million)
    1. Hospitals
    2. Specialty Clinics
    3. Ambulatory Surgical Center
    4. Research and Academic Institutes
  5. Country Level Analysis, Value (USD Million)
    1. UK
    2. Germany
    3. France
    4. Italy
    5. Spain
    6. NORDIC
    7. Russia
    8. Rest of Europe
Asia Pacific Market
1. Overview
  1. Market Value (USD Million), Current and Future Projections, 2024-2037
  2. Increment $ Opportunity Assessment, 2024-2037
  3. Year-on-Year Growth Forecast (%)
2. Segmentation (USD Million), 2024-2037, By
  1. Type, Value (USD Million)
    1. Synthetic Pericardial Patches
    2. Biological Pericardial Patches
      1. Autologous
      2. Xenograft
  2. Source, Value (USD Million)
    1. Bovine
    2. Porcine
    3. Equine
    4. Others
  3. Application, Value (USD Million)
    1. Cardiovascular Surgery
    2. Heart Valve Repair
    3. Congenital Heart Defects
    4. Dental Surgery
    5. Others
  4. End user, Value (USD Million)
    1. Hospitals
    2. Specialty Clinics
    3. Ambulatory Surgical Center
    4. Research and Academic Institutes
  5. Country Level Analysis, Value (USD Million)
    1. China
      1. Hong Kong
    2. Japan
    3. India
    4. Australia
    5. South Korea
    6. Vietnam
    7. Thailand
    8. Singapore
    9. Malaysia
    10. Rest of Asia Pacific
Latin America Market
1. Global Overview
  1. Market Value (USD Million), Current and Future Projections, 2024-2037
  2. Increment $ Opportunity Assessment, 2024-2037
  3. Year-on-Year Growth Forecast (%)
2. Global Segmentation (USD Million), By
  1. Type, Value (USD Million)
    1. Synthetic Pericardial Patches
    2. Biological Pericardial Patches
      1. Autologous
      2. Xenograft
  2. Source, Value (USD Million)
    1. Bovine
    2. Porcine
    3. Equine
    4. Others
  3. Application, Value (USD Million)
    1. Cardiovascular Surgery
    2. Heart Valve Repair
    3. Congenital Heart Defects
    4. Dental Surgery
    5. Others
  4. End user, Value (USD Million)
    1. Hospitals
    2. Specialty Clinics
    3. Ambulatory Surgical Center
    4. Research and Academic Institutes
  5. Country Level Analysis, Value (USD Million)
    1. Brazil
    2. Mexico
    3. Argentina
    4. Rest of Latin America
Middle East & Africa Market
1. Global Overview
  1. Market Value (USD Million), Current and Future Projections, 2024-2037
  2. Increment $ Opportunity Assessment, 2024-2037
  3. Year-on-Year Growth Forecast (%)
2. Global Segmentation (USD Million), By
  1. Type, Value (USD Million)
    1. Synthetic Pericardial Patches
    2. Biological Pericardial Patches
      1. Autologous
      2. Xenograft
  2. Source, Value (USD Million)
    1. Bovine
    2. Porcine
    3. Equine
    4. Others
  3. Application, Value (USD Million)
    1. Cardiovascular Surgery
    2. Heart Valve Repair
    3. Congenital Heart Defects
    4. Dental Surgery
    5. Others
  4. End user, Value (USD Million)
    1. Hospitals
    2. Specialty Clinics
    3. Ambulatory Surgical Center
    4. Research and Academic Institutes
  5. Country Level Analysis, Value (USD Million)
    1. GCC
    2. Israel
    3. South Africa
    4. Rest of Middle East & Africa
Global Economic Scenario
1. World Economic Outlook
About Research Nester
1. Our Global Clientele
2. We Serve Clients Across World

Global Market Size, Forecast, and Trend Highlights Over 2025-2037

Pericardial Patches Market size was valued at USD 336.8 million in 2024 and is projected to reach a valuation of USD 777.9 million by the end of 2037, rising at a CAGR of 6.6% during the forecast period, i.e., 2025-2037. In 2025, the industry size of pericardial patches is assessed at USD 358.8 million.

The pericardial patches market is anticipated to rise at a steady pace due to advances in cardiovascular surgery and the rise in the prevalence of heart diseases. These patches, applied to various surgical techniques, offer superior biocompatibility and flexibility for better performance in patient outcomes. Key players in the market have been introducing new, innovative products targeting different surgical needs. In April 2023, Aziyo Biologics signed a distribution agreement with LeMaitre Vascular to distribute various products, such as ProxiCor PC, to further strengthen its cardiovascular segment. This reflects the growing trend of company collaborations in developing superior product offerings and gaining broader pericardial patches market access.

The demand for pericardial patches is driven by integrating advanced technologies, including bioengineering and synthetic materials. Furthermore, government regulatory authorities also impose strict quality standards to ensure safety and effectiveness, which aligns with growing consumer expectations for sophisticated medical solutions. For instance, in the U.S., The FDA has imposed new guidelines, which include stringent tests for the biocompatibility and performance of medical devices. This ascertains that pericardial patches meet high standards of safety before they reach the market.

Get more information on this report: Request Free Sample PDF

Pericardial Patches Sector: Growth Drivers and Challenges

Growth Drivers

Increasing prevalence of cardiovascular diseases: The increasing burden of cardiovascular diseases across geographies has raised the demand for advanced surgical solutions. Pericardial patches have been considered for cardiac repairs due to their resistance and biocompatibility. These products are in high demand, which has grown with the expansion of minimally invasive options. For example, in January 2023, Cardiac Dimensions broadened access to its Carillon Mitral Contour System across additional European markets. This device provides a minimally invasive solution for functional mitral regurgitation by reshaping the mitral annulus. As a result, the prevalence of these diseases contributes directly to the growth of the market.
Development and advances in biocompatible materials: The advancement in the development of biocompatible materials is another factor driving the demand for pericardial patches. Biologic patches derived from bovine and porcine tissues offer better integration and less immune response. As a result, they are finding increased adoption in cardiovascular surgical procedures. For example, in January 2022, Artivion introduced the PROACT Mitral Valve in Europe market. This mechanical heart valve is designed to enhance durability and hemodynamics for patients needing mitral valve replacement, with the goal of minimizing reliance on anticoagulation therapy. These improved products are setting new benchmarks in cardiac care and repair.
Government and private investments in R&D: Increasing investments in research and development are driving the pericardial patches market expansion, opening new paths to collaboration between producers and healthcare providers. One example of such innovation is the introduction of the BIO-A FLEX Patch by W.L. Gore & Associates in March 2023 for complex soft tissue repair. These investments epitomize the focus on solving complex surgical challenges with better outcomes for patients. Furthermore, the infusion of funds into R&D is a key growth driver, allowing technology to enable next-generation medical solutions.

Challenges

Stringent regulatory approvals: Strict regulatory approvals pose a significant challenge in the pericardial patches market. These are long-drawn procedures comprising hard testing, elaborate documentation, and compliance matters, often resulting in extended timelines for product approvals. Increased research and development costs result from the complications in meeting such standards. Furthermore, variation in different regulatory guidelines around the globe further complicates entry into the global market. Together, these factors slow down innovation and postpone the launch of new products.
Limited awareness in emerging markets: A major challenge is a lack of awareness about pericardial patches and their applications in emerging markets. Many medical professionals and patients in these regions are still unaware of the advantages of such devices. This is compounded by the general lack of robust infrastructure and access to modern medical technologies. Furthermore, financial constraints and focus on basic healthcare services are further causing governments to shift their attention away from the adoption of specialty medical products. Lack of awareness and availability, therefore, restrain the growth prospects of the market in these regions.

Pericardial Patches Market: Key Insights

Base Year	2024
Forecast Year	2025-2037
CAGR	6.6%
Base Year Market Size (2024)	USD 336.8 million
Forecast Year Market Size (2037)	USD 777.9 million
Regional Scope	North America (U.S., and Canada) Asia Pacific (Japan, China, India, Indonesia, Malaysia, Australia, South Korea, Rest of Asia Pacific) Europe (UK, Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe) Latin America (Mexico, Argentina, Brazil, Rest of Latin America) Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)

Get more information on this report: Request Free Sample PDF

Pericardial Patches Segmentation

Type (Synthetic Pericardial Patches, Biological Pericardial Patches)

In pericardial patches market, biological pericardial patches segment is projected to dominate revenue share of around 88% by the end of 2037. These patches are preferred owing to their superior biocompatibility with low chances of immune rejection compared to the synthetic alternative. This wide use in cardiac and vascular surgery underlines their clinical effectiveness. In January 2020, Tendyne marked a milestone by completing the first commercial implantation of its Transcatheter Mitral Valve System using a biological patch, furthering minimally invasive treatments. The preference for these products points toward their important position in modern surgical applications.

Source (Bovine, Porcine, Equine, Others)

By 2037, bovine segment is set to dominate pericardial patches market share of over 40.4%. The growth of the segment can be attributed to the performance that bovine materials display while being used in pericardial applications, such as cardiovascular repairs. Furthermore, with enhancements in processing techniques, durability and compatibility also improve, making them adaptable for medical use. Their application in a variety of surgical procedures underlines their growing relevance. The growth in this segment reflects the demand for dependable and biocompatible materials in healthcare.

Our in-depth analysis of the pericardial patches market includes the following segments

Type	Synthetic Pericardial Patches Biological Pericardial Patches
Source	Bovine Porcine Equine Others
Application	Cardiovascular Surgery Heart Valve Repair Congenital Heart Defects Dental Surgery Others
End user	Hospitals Specialty Clinics Ambulatory Surgical Center Research and Academic Institutes

Want to customize this research report as per your requirements? Our research team will cover the information you require to help you take effective business decisions.

Customize this Report

North America Market Analysis

By the end of 2037, North America pericardial patches market is set to hold over 37.8% revenue share. This leadership is driven by the region's strong healthcare infrastructure and significant investment in cardiovascular research and treatment advancements. A key development highlighting this focus is the acquisition by Baxter International Inc. of the PerClot Polysaccharide Hemostatic System from CryoLife, Inc., in July 2021, for as much as USD 60.8 million, including an up-front payment of USD 25 million. The transaction marked Baxter's strategic entry into the hemostatic powder segment and strengthened its portfolio considerably with active and passive hemostatic solutions.

The U.S. is predicted to dominate the pericardial patches market in North America. A strong network of cardiovascular centers with a high level of specialization and a high degree of adoption of advanced medical technologies drives the demand for these products. The regulatory environment, though strict, allows for innovation with well-defined pathways for product approvals, as evidenced by the rapid adoption of novel solutions such as the Integrity Implant System. This focus on addressing complex cardiovascular conditions ensures steady pericardial patches market growth in the country.

Canada also accounts for a major share of the North America pericardial patches market due to its advanced healthcare system and wide accessibility of surgical treatments. The country focuses on collaboration between research institutions and medical device manufacturers, thus encouraging innovation in pericardial patch technology. Having nearly half the population size compared to the United States, the total expenditures spent on healthcare by Canada were estimated at USD 9,054 per capita, growing 5.7 percent from the previous year of estimation, which boosts its steady contribution towards regional market growth.

Asia Pacific Market Statistics

Asia Pacific pericardial patches market is expected to showcase growth rate of around 7.2% between 2024 and 2037 due to enhanced access to healthcare and increasing awareness about cardiovascular treatments. Large populations, especially in countries like India and China, along with a rise in the prevalence of heart-related conditions, create significant demand for sophisticated medical solutions. In addition, the initiatives taken by the government for better healthcare infrastructure and promotion of advanced surgical technologies further complement market growth. Thus, all these factors have put the region as one of the major contributors toward the global growth of the pericardial patches market.

India is also emerging as a significant market in Asia Pacific due to the rising burden of cardiovascular diseases and improving healthcare infrastructure. The government's focus on accessing advanced medical technologies further boosts the adoption of pericardial patches. This is evident from the fact that nearly 24.8% of all deaths in India are related to cardiovascular diseases, creating an immediate need for innovative medical solutions such as pericardial patches.

China is a significant growth influencer in the Asia Pacific for pericardial patches, impelled by the rapid strengthening of healthcare infrastructure and considerable patient pools. Central government encouragement has been done to increase medical device manufacturing, thereby promoting improved cardiovascular product development. At present, nearly 106 million patients in the country have cardiovascular disease, thus necessitating effective treatments of surgery. This underlines the critical use of effective surgical solutions and positions China as a significant facilitator in regional market spread.

Get more information on this report: Request Free Sample PDF

Companies Dominating the Pericardial Patches Landscape

The pericardial patches market is highly competitive and consists of leading players such as Abbott Laboratories, Baxter International, Collagen Solutions LLC, Edwards Lifesciences Corporation, and LeMaitre Vascular, Inc. These companies are investing heavily in research and development to develop next-generation products for emerging needs in surgery. Strategic partnerships and acquisitions are further enhancing their market reach and strengthening their global presence. This is clearly seen within the focus of their product pipelines, aiming to address the complexities in cardiovascular repairs. These companies continue leveraging the latest technology and clinical expertise to compete. When interacting with each other, these aspects make the pericardial patches market environment dynamic and geared toward growth.

In January 2024, Neovasc announced positive results from its pivotal trial of the Tiara bioengineered patch. The Tiara patch, designed for precise bioengineering, represents a breakthrough in tackling complex cardiac conditions. This is a sign that the companies in the industry are committed to innovation and underlines the focus of the entire industry on meeting critical needs in cardiovascular care. These results pave the way for potential regulatory approval, reflecting the competitive drive to bring advanced solutions to the market. Furthermore, such developments illustrate the high stakes and rapid pace of innovation characterizing the pericardial patches industry.

Here are some leading companies in the pericardial patches market

ARTIVION, Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
Abbott Laboratories
Baxter International.
Collagen Solutions LLC
Edwards Lifesciences Corporation
FOC Medical S.A.
Labcor Laboratórios Ltd
LeMaitre Vascular, Inc.
Visionary Medtech Solutions Pvt. Ltd.
W. L. Gore & Associates, Inc.

In the News

In February 2024, Terumo Medical Corporation partnered with InHeart Pharma to develop a bioresorbable patch for atrial fibrillation, aiming to advance minimally invasive treatments for this condition, which is closely linked to increased stroke risk. This collaboration underscores Terumo’s dedication to delivering innovative solutions in cardiac care.
In December 2023, TEI Biosciences Inc. received FDA 510(k) clearance for its DermaMatrix Advanced Wound Care Patch, designed to treat diabetic foot ulcers, thereby expanding their product portfolio and addressing a significant unmet need in wound care. This approval further cements TEI’s leadership in regenerative wound treatment.
In October 2023, LeMaitre Vascular formed a strategic partnership with Aziyo Biologics to distribute Aziyo's cardiovascular and soft tissue repair products, enhancing LeMaitre's product offerings and bolstering its position in the market. This alliance combines both companies’ strengths to improve surgical outcomes.

Author Credits: Radhika Pawar

Report ID: 4589
Published Date: Nov 29, 2024
Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In 2024, the industry size of pericardial patches was USD 336.8 million.

The global pericardial patches market size was USD 336.8 million in 2024 and is expected to reach USD 777.9 million by the end of 2037, expanding at a CAGR of 6.6% during the forecast period, i.e., 2025-2037. In 2025, the industry size of pericardial patches will be valued at USD 358.8 million.

Key players in the market are Abbott Laboratories, Baxter International., Collagen Solutions (US) LLC, Edwards Lifesciences Corporation, FOC Medical S.A., Labcor Laboratórios Ltd, LeMaitre Vascular, Inc., Visionary Medtech Solutions Pvt. Ltd., and W. L. Gore & Associates, Inc.

The biological pericardial patches segment is predicted to lead the market during the forecast period.

Asia Pacific is anticipated to become a lucrative market for companies in the pericardial patches market during the forecast period.